The Global Pregabalin market was valued at US $743.23 Mn. in 2020, and it is expected to reach US $957.81 Mn. by 2027 with a CAGR of 3.69% during the forecast period. Pregabalin is an anticonvulsant and anxiolytic drug that is used to treat a variety of disorders, including epilepsy, neuropathic pain, fibromyalgia, restless leg syndrome, and generalised anxiety disorder. It's a type of epilepsy treatment that's used to treat partial seizures. When given before surgery, it reduces pain but also causes sleepiness and visual disturbances of epilepsy patients live in low- and middle-income countries during the early stages of the disease.
read more..